Alcohol Aftereffects, Anxiety, Cognitive Impairment
Conditions
Keywords
Cognitive Function, Hangover, Anxiety Reduction
Brief summary
This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.
Interventions
DIETARY_SUPPLEMENTJoyRise Recovery Powder
JoyRise Recovery Powder is a dietary supplement that contains Dihydromyricetin (DHM) and other natural ingredients. It is designed to mitigate the aftereffects of alcohol consumption. Participants will mix one serving in 8-12 oz of water and consume it the morning after alcohol consumption.
DIETARY_SUPPLEMENTPlacebo
A placebo solution that is visually and tastefully similar to JoyRise Recovery Powder but contains no active ingredients. It will be mixed in 8-12 oz of water and consumed the morning after alcohol consumption.
Sponsors
Citruslabs
Joyrise
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
This study uses a double-blind design, meaning that both the participants and the investigators are unaware of the group assignments.
Intervention model description
This is a randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy of JoyRise Recovery Powder in mitigating the aftereffects of alcohol consumption. The study involves two groups: one receiving the active supplement (JoyRise Recovery Powder) and the other receiving a placebo.
Eligibility
Sex/Gender
ALL
Age
35 Years to 54 Years
Healthy volunteers
Yes
Inclusion criteria
* Aged 35-54, male or female * Regular alcohol consumption * Event planned within one month that involves alcohol consumption * Willingness to avoid new medications or supplements during the study period * Must confirm that they will not drive while under the influence of alcohol.
Exclusion criteria
* Anyone not in good health. * Anyone who has any chronic health conditions such as oncological or psychiatric disorders. * Anyone who has any known serious allergic reactions that require the use of an Epi-Pen. * Anyone who is pregnant, breastfeeding, or trying to conceive. * Anyone who cannot/ will not commit to the study protocol. * Anyone with a history of substance abuse. * Anyone who has undergone an invasive medical procedure in the six months prior to the study, or has a procedure planned during the study duration. * Anyone currently using any medications that may affect their response to alcohol or impact hangover symptoms, such as diuretics (water pills) or medication for hypertension. * History of severe reactions or sensitivity to alcohol. * Anyone currently taking glutathione.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in Symptoms Associated with Alcohol Aftereffects | Baseline and 30 minutes after product consumption on the day following alcohol consumption. | Measurement of the reduction in alcohol aftereffects using the Alcohol Hangover Questionnaire (AHQ). Participants will self-report their symptoms, such as headache, nausea, and tiredness. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in Cognitive Function | Baseline and 30 minutes after product consumption on the day following alcohol consumption. | Measurement of cognitive function using Double Trouble (which assesses selective attention and processing speed). Participants will complete this assessment to determine any changes in cognitive function. |
| Reduction in Feelings of Anxiousness | Baseline and 30 minutes after product consumption on the day following alcohol consumption. | Measurement of reduction in feelings of anxiousness using self-reported questionnaires. Participants will rate their anxiety levels to determine if the product provides a calming effect. |
| Increased User Satisfaction with Overall Well-being | Baseline and 4+ hours after product consumption on the day following alcohol consumption. | Measurement of user satisfaction with overall well-being through self-reported questionnaires. Participants will rate their satisfaction with their physical and mental state post-alcohol consumption. |
Countries
United States
Outcome results
None listed